Trump ‘enthusiastic’ about Dem’s drug cost proposal: 4 things to know

Reps. Elijah Cummings, D-Md., and Peter Welch, D-Vt., on Wednesday met with President Donald Trump to discuss strategies for lowering drug costs, reports Kaiser Health News.

Advertisement

Here are four things to know.

1. HHS Secretary Tom Price and Redonda Miller, MD, president of The Johns Hopkins Hospital in Baltimore, also sat in on the White House meeting.

2. Reps. Cummings and Welch shared a draft of a House bill that would allow the federal government to negotiate drug costs.

3. President Trump was “aware of the problem” of high drug costs and “enthusiastic” about tackling the issue, according to Rep. Cummings.

“He made it clear to us that he wanted to do something,” Rep. Cummings said, according to KHN.

4. The congressmen said they gave President Trump and Dr. Price the bill to review and make comments. Rep. Cummings hopes to file the bill in two weeks, according to the report.

More articles on supply chain:

ACA replacement plan would nix medical device tax: 4 things to know
How beneficial are drug price transparency measures? 5 thoughts
Trump tweets about plan to lower drug prices, pharma stocks fall

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.